Shares of American Capital, Ltd. (ACAS) jumped 1.72% on Friday, following the divesture of its portfolio company Avalon Laboratories Holding Corp. to Nordson Corp. (NDSN). Notably, Nordson is a world-leading precision fluid dispensing systems manufacturer.
The company and its affiliated fund – American Capital Equity III, LP (ACE III) — received $180 million for the deal. The company has earned 19% compounded annual rate of return over the life of its investment, including dividends and fees.
Based in Los Angeles, Avalon designs and manufactures highly-specialized, single-use catheters and specialty medical tubing products for cardiology, pulmonology and related applications. Primary customers for the company include OEM customers in the cardiology, pulmonology, endovascular, bariatrics, tracheostomy, endoscopy, non-vascular stent and ophthalmic market segments.
Avalon was the first exit for ACE III. In spite of the global recession, the company recorded a solid financial performance, generating double-digit annual revenue and EBITDA growth.
American Capital directly and through its asset management business initiates, underwrites and manages investments in middle-market private equity, leveraged finance, real estate and structured products. Since its IPO in 1997 through the second quarter of 2014, the company has earned a 23% compounded annual return on the exit of its equity investments, including dividends, fees and net gains.
American Capital carries a Zacks Rank #5 (Strong Sell). Some better-ranked stocks in the same industry include Medallion Financial Corp. (TAXI) and Apollo Investment Corp. (AINV). Both companies carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment